financetom
Business
financetom
/
Business
/
Heramba Electric Reports Non-Compliance With Nasdaq Listing Rule
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Heramba Electric Reports Non-Compliance With Nasdaq Listing Rule
Mar 18, 2025 2:06 AM

04:51 AM EDT, 03/18/2025 (MT Newswires) -- Heramba Electric ( PITA ) said late Monday it received a delinquency notification letter from the Nasdaq Stock Market, indicating non-compliance with the bourse's listing rule.

The closing bid price for the company's ordinary shares was below $1 apiece for 30 consecutive business days, resulting in non-compliance with the minimum bid price requirement.

The company said it has until Sept. 8 to regain compliance failing which it may be eligible for additional time to become compliant.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
What's Going On With DraftKings Stock?
What's Going On With DraftKings Stock?
Jun 10, 2024
DraftKings Inc ( DKNG ) shares are trading higher Monday. The company filed for a mixed shelf offering on Friday before being named a top pick by Morgan Stanley this week. What To Know: After the market close on Friday, DraftKings ( DKNG ) filed a prospectus supplement for the proposed sale of up to 7.5 million shares of its...
TOMI Environmental Solutions Signs Two Sales Agreements
TOMI Environmental Solutions Signs Two Sales Agreements
Jun 10, 2024
11:15 AM EDT, 06/10/2024 (MT Newswires) -- TOMI Environmental Solutions ( TOMZ ) said Monday it has agreed to sell SteraMist Environment System and TOMI validation services to a pharmaceutical company for its vivarium facility in Mexico. Financial details of the agreement and name of the client were not disclosed. TOMI said it also agreed to sell SteraMist Hybrid System...
Arcus Completes Enrollment in Phase 3 Trial of Domvanalimab-Containing Regimen for Stomach Cancer
Arcus Completes Enrollment in Phase 3 Trial of Domvanalimab-Containing Regimen for Stomach Cancer
Jun 10, 2024
11:15 AM EDT, 06/10/2024 (MT Newswires) -- Arcus Biosciences ( RCUS ) said Monday it completed the patient enrollment in a phase 3 trial of an experimental combination therapy of domvanalimab, zimberelimab and chemotherapy for people with upper gastrointestinal adenocarcinoma. About 1,050 participants with locally advanced unresectable or metastatic gastric, gastroesophageal junction, or esophageal adenocarcinoma have been enrolled for the...
BRIEF-Trump Media & Technology Files Prospectus For Issuance Of Up To 14.4 MLN Shares Upon Exercise Of Public Warrants
BRIEF-Trump Media & Technology Files Prospectus For Issuance Of Up To 14.4 MLN Shares Upon Exercise Of Public Warrants
Jun 10, 2024
June 10 (Reuters) - Trump Media & Technology Group Corp ( DJT ) : * TRUMP MEDIA & TECHNOLOGY ( DJT ): FILES PROSPECTUS RELATED TO ISSUANCE OF UP TO 14.4 MILLION SHARES UPON EXERCISE OF PUBLIC WARRANTS ORIGINALLY ISSUED IN IPO OF DWAC * TRUMP MEDIA & TECHNOLOGY ( DJT ): HAD PREVIOUSLY FILED PROSPECTUS RELATED TO ISSUANCE OF...
Copyright 2023-2026 - www.financetom.com All Rights Reserved